ZHANG Hui , FAN Yue-zu , WANG Jin-si , LIN Meng-bo . The origin of carcinoma-associated fibroblasts and its molecular mechanisms[J]. Surgical Research and New Technique, 2014 , 3(1) : 1 -7 . DOI: 10.3969/j.issn.2095-378X.2014.01.001

[1] Balkwill F,Mantovani A.Inflammation and cancer:back to Virchow?[J].Lancet,2001,357(9255):539-545.
[2] Wever OD,Mareel M.Role of tissue stroma in cancer cell invasion[J].J Pathol,2003,200(4):429-447.
[3] Xouri G,Christian S.Origin and function of tumor stroma fibroblasts[J].Semin Cell Dev Biol,2010,21(1):40-46.
[4] Mueller MM,Fusenig NE.Friends or foes-Bipolar effects of the tumour stroma in cancer[J].Nature Reviews Cancer,2004,4(11):839-849.
[5] Sugimoto H,Mundel TM,Kieran MW,et al.Identification of fibroblast heterogeneity in the tumor microenvironment[J].Cancer Biol Therapy,2006,5(12):1640-1646.
[6] Park JE,Lenter MC,Zimmermann RN,et al.Fibroblast activation protein,a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts[J].J Biol Chem1999,274(51):36505-36512.
[7] Ostman A,Augsten M.Cancer-associated fibroblasts and tumor growth-bystanders turning into key players[J].Curr Opin Genet Dev,2009,19(1):67-73.
[8] Tyan SW,Kuo WH,Huang CK,et al.Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis[J].PLoS One,2011,6(1):5313.
[9] Liao CP,Adisetiyo H,Liang M,et al.:Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells[J].Cancer Res,2010,70(18):7294-7303.
[10] Zhi K,Shen X,Zhang H,et al.Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers[J].J Exp Clin Cancer Res,2010,29(8):66.
[11] Shinagawa K,Kitadai Y,Tanaka M,et al.Mesenchymal stem cells enhance growth and metastasis of colon cancer[J].Int J Cancer 2010,127(10):2323-2333.
[12] Zhang YA,Tang HJ,Cai J,et al.Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis,lymphangiogenesis and tumor cell invasion[J].Cancer Lett,2011,303(1):47-55.
[13] Angeli F KG,Chen MC,Kumar S,et al.Role of stromal fibroblasts in cancer:promoting or impeding?[J].Tumor Biol ,2009,30(3):109-120.
[14] Zeisberg RKM.Fibroblasts in cancer.Nature Reviews Cancer,2006,6(5):392-401.
[15] Anderberg C,Li H,Fredriksson L,et al.Paracrine signaling by platelet-derived growth factor-C promotes tumor growth by recruitment of cancer-associated fibroblasts[J].Cancer Res,2009,69(1):69-378.
[16] Augsten M,Hgglf C,Pea C,et al.A digest on the role of the tumor microenvironment in gastrointestinal Cancers[J].Cancer Microenvironment,2010,3(1):167-176.
[17] Fukino K,Shen L,Patocs A,et al.Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma[J].JAMA,2007,297(19):2103-2111.
[18] Frank Weber,Yaomin Xu,Li Zhang.Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma[J].JAMA,2007,297(2):187-195.
[19] Qiu W,Hu M,Sridhar A,et al.No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas[J].Nature Genetics,2008,40(5):650-655.
[20] Walter K,Omura N,Hong SM,et al.Brief report:pancreatic cancer associated fibroblasts display normal allelotypes[J].Cancer Biol Therapy,2008,7(6):882-888.
[21] Allen M,Louise Jones J.Jekyll and Hyde:the role of the microenvironment on the progression of cancer[J].J Pathol,2011,223(2):163-177.
[22] Hinshelwood RA,Huschtscha LI,Melki J,et al.Concordant epigenetic silencing of transforming growth factor-signaling pathway genes occurs early in breast carcinogenesis[J].Cancer Res,2007,67(24):11517-11527.
[23] Tsujino T,Seshimo I,Yamamoto H,et al.Stromal myofibroblasts predict disease recurrence for colorectal cancer[J].Clin Cancer Res,2007,13(7):2082-2090.
[24] Paulsson J,Sjblom T,Micke P,et al.Prognostic significance of stromal platelet-derived growth factor β-receptor expression in human breast cancer[J].Am J Pathol,2009,175(1):334-341.
[25] Kurose K,Gilley K,Matsumoto S,et al.Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas[J].Nature Genetics,2002,32(3):355 - 357
[26] Weber F,Fukino K,Sawada T,et al.Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors[J].Br J Cancer,2005,92(10):1922-1926.
[27] Hu M,Yao J,Cai L,et al.Distinct epigenetic changes in the stromal cells of breast cancers[J].Nature Genetics,2005,37(8):899-905.
[28] Barcellos-Hoff MH,Ravani SA.Irradiated Mammary Gland Stroma Promotes the Expression of Tumorigenic Potential by Unirradiated Epithelial Cells[J].Cancer Res,2000,60(5):1254-1260.
[29] Ohuchida K,Mizumoto K,Murakami M,etal.Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions[J].Cancer Res,2004,64(9):3215-3222.
[30] Mercier I,Casimiro MC,Wang C,et al.Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation:Implications for the response to hormonal therapy[J].Cancer Biol Ther,2008,7(8):1212-1225.
[31] Bauer M,Su G,Casper C,et al.Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast[J].Oncogene,2010,29(12):1732-1740.
[32] Patocs A,Zhang L,Xu YM,et al.Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases[J].N Engl J Med,2007,357(25):2543-2551.
[33] Polyak K,Haviv I,Campbell IG.Co-evolution of tumor cells and their microenvironment[J].Trends in Genetics,2009,25(1):30-38.
[34] Campbell I,Qiu W,Haviv I.Genetic changes in tumour microenvironments[J].J Pathol,2011,223(4):450-458.
[35] Casey TM,Eneman J,Crocker A,et al.Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells:a population study[J].Breast Cancer Res Treat,2007,110(1):39-49.
[36] Haubeiss S,Schmid JO,Muerdter TE,et al.Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts[J].Mo Cancer,2010,27(9):168.
[37] Dudás J,Bitsche M,Schartinger V,et al.Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells[J].Oral Oncol,2011,47(2):98-103.
[38] Huber MA,Kraut N,Beug H.Molecular requirements for epithelial-mesenchymal transition during tumor progression[J].Cur Opin Cell Biol,2005,17(5):548-558.
[39] Polyak K,Weinberg RA.Transitions between epithelial and mesenchymal states:acquisition of malignant and stem cell traits[J].Nature Reviews Cancer,2009,9(4):265-273.
[40] Hazan RB,Qiao R,Keren R,et al.Cadherin Switch in Tumor Progression[J].Ann N Y Acad Sci,2004,Apr,1014:155-163.
[41] Medici D,Hay ED,Olsen BR.Snail and Slug promote epithelial-mesenchymal transition through β-catenin-T-cell factor-4-dependent expression of transforming growth factor-β3[J].Mol Biol Cell,2008,19(11):4875-4887.
[42] Kalluri R,Weinberg RA.The basics of epithelial-mesenchymal transition[J].J Clin Invest,2009,119(6):1420-1428.
[43] Peinado H,Olmeda D,Cano A.Snail,Zeb and bHLH factors in tumour progression:an alliance against the epithelial phenotype? [J].Nature Reviews Cancer,2007,7(6):415-428.
[44] Acloque H,Thiery JP,Nieto MA.The physiology and pathology of the EMT.Meeting on the Epithelial-Mesenchymal Transition[J].EMBO reports,2008,9(4):322-326.
[45] Wyatt L,Wadham C,Crocker LA,et al.The protein tyrosine phosphatase Pez regulates TGFβ,epithelial-mesenchymal transition,and organ development[J].J Cell Biol,2007,178(7):1223-1235.
[46] Waerner T,Alacakaptan M,Tamir I,et al.ILEI:A cytokine essential for EMT,tumor formation,and late events in metastasis in epithelial cells[J].Cancer Cell,2006,10(3):227-239.
[47] Thuault S,Valcourt U,Petersen M,et al.Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition[J].J Cell Biol,2006,174(2):175-183.
[48] Laberge RM,Awad P,Campisi J,et al.Epithelial-mesenchymal transition induced by senescent fibroblasts[J].Cancer Microenviron,2012,5(1):39-44.
[49] Moustakas A,Heldin C-H.Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression[J].Cancer Sci,2007,98(10):1512-1520.
[50] Massagué J.TGFβ in Cancer[J].Cell,2008,134(2):215-230.
[51] Mercado-Pimentel ME,Runyan RB.Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart[J].Cells Tissues Organs,2007,185(1-3):146-156.
[52] Bailey JM,Singh PK,Hollingsworth MA.Cancer metastasis facilitated by developmental pathways:Sonic hedgehog,Notch,and bone morphogenic proteins[J].J Cell Biochem,2007,102(4):829-839.
[53] Wang Z,Banerjee S,Li Y,et al.Down-regulation of Notch-1 Inhibits Invasion by Inactivation of Nuclear Factor-κB,Vascular Endothelial Growth Factor,and Matrix Metalloproteinase-9 in Pancreatic Cancer Cells[J].Cancer Res,2006,66(5):2778-2784.
[54] Zhang C,Carl TF,Trudeau ED,et al.An NF-κB and Slug regulatory loop active in early vertebrate mesoderm[J].PLoS One,2006,27(1):e106.
[55] Julien S,Puig I,Caretti E,et al.Activation of NF-B by Akt upregulates Snail expression and induces epithelium mesenchyme transition[J].Oncogene,2007,26(53):7445-7456.
[56] Suzuki H,Watkins DN,Jair K-W,et al.Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer[J].Nature Genetics,2004,36(4):417-422.
[57] Zhang W,Glckner SC,Guo M,et al.Epigenetic inactivation of the canonical Wnt antagonist SRY-Box containing gene 17 in colorectal cancer[J].Cancer Res,2008,68(8):2764-2772.
[58] Aguilera O,Fraga MF,Ballestar E,et al.Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer[J].Oncogene,2006,25(29):4116-4121.
[59] Hugo H,Ackland ML,Blick T,et al.Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression[J].J Cell Physiol,2007,213(2):374-383.
[60] Cannito S,Novo E,Compagnone A,et al.Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells[J].Carcinogenesis,2008,29(12):2267-2278.
[61] Vooijs MA,Gort EH,Groot AJ,et al.Hypoxic regulation of metastasis via hypoxia-inducible factors[J].Cur Mol Med,2008,8(1):60-67.
[62] Dunbier A,Guilford P.Hereditary diffuse gastric cancer[J].Advances Cancer Res,2001,83(1):55-65.
[63] Bloushtain-Qimron N,Yao J,Snyder EL,et al.Cell type-specific DNA methylation patterns in the human breast[J].Nat Acad Sci USA,2008,105(37):14076-14081.
[64] Thiery JP,Acloque H,Huang RY,et al.Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139(5):871-890.
[65] Zeisberg EM,Potenta S,Xie L,et al.Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts[J].Cancer Res,2007,67(21):10123-10128.
[66] Potenta S,Zeisberg E,Kalluri R.The role of endothelial-to-mesenchymal transition in cancer progression[J].Br J Cancer,2008,99(9):1375-1379.
[67] Timmerman LA,Grego-Bessa J,Raya A,et al.Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation[J].Genes Dev,2004,18(1):99-115.
[68] Barry FP,Murphy JM.Mesenchymal stem cells:clinical applications and biological characterization[J].Int J Biochem Cell Biol,2004,36(4):568-584.
[69] Studeny M,Marini FC,Dembinski JL,et al.Mesenchymal stem cells:Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents[J].J Nat Cancer Inst,2004,96(21):1593-1603.
[70] Direkze NC.Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts[J].Cancer Res,2004,64(23):8492-8495.
[71] Ogawa M,LaRue AC,Drake CJ.Hematopoietic origin of fibroblasts/myofibroblasts:Its pathophysiologic implications[J].Blood,2006,108(9):2893-2896.
[72] Mishra PJ,Humeniuk R,Medina DJ,et al.Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells[J].Cancer Res,2008,68(11):4331-4339.
[73] Jeon ES,Lee IH,Heo SC,et al.Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism[J].Biochim Biophys Acta-Mol Cell Biol Lipids,2010,1801(11):1205-1213.